DNAJB9 and lipoprotein glomerulopathy: In eight patients, glomerulopathy was identified, including focal and segmental glomerulosclerosis (FSGS, n = 4), membranous nephropathy (n = 3), and DNAJB9+ fibrillar glomerulonephritis (n = 1).